IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters 15-May-2023 / 22:50 CET/CEST Release of an ad hoc
IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report15-May-2023 / 22:50 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.IGEA to update on unaudited key figures and ongoing matters Hoofddorp, the Netherlands, 15 M.
IGEA Pharma N.V. / Key word: Annual Results/Annual Results
IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure
01-May-2023 / 23:46 CET/CEST
Release of an ad hoc. | May 1, 2023
IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure 01-May-2023 / 23:46 CET/CEST Release of an ad hoc announcement